Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$68.93 USD

68.93
3,935,175

+0.18 (0.26%)

Updated Sep 4, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

What Makes Edwards Lifesciences (EW) a New Buy Stock

Edwards Lifesciences (EW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Tracey Ryniec headshot

Stock Investors: Do You Need a Late Cycle Plan?

The financial media keeps talking about the economy being in the late cycle but that doesn't mean you can't be buying stocks.

Edwards Lifesciences Hits a 52-Week High on Solid Prospects

Edwards Lifesciences (EW) gains from recent impressive developments.

Here's Why You Should Invest in Edwards Lifesciences (EW) Now

Investors continue to be optimistic about Edwards Lifesciences' (EW) performance.

Edwards Lifesciences Sapien 3 System Recall Classified Class I

Edwards Lifesciences (EW) initiated the Field Corrective Action after receiving reports of 17 injuries and a death from the use of the Sapien 3 Ultra delivery system.

Why Is Edwards Lifesciences (EW) Up 3.2% Since Last Earnings Report?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Edwards Lifesciences' (EW) SAPIEN 3 TAVR Receives FDA Nod

Edwards Lifesciences (EW) plans a commercial introduction of SAPIEN 3 Ultra in Europe.

HMS Holdings (HMSY) Soars to 52-Week High, Time to Cash Out?

HMS Holdings (HMSY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here is Why Growth Investors Should Buy Edwards Lifesciences (EW) Now

Edwards Lifesciences (EW) could produce exceptional returns because of its solid growth attributes.

Edwards Lifesciences Corporation (EW) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Edwards Lifesciences Corporation (EW).

Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View

Edwards Lifesciences (EW) Q2 results benefit from higher revenues, strong segmental performance and gross margin expansion.

Edwards Lifesciences (EW) Q2 Earnings and Revenues Top Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.76% and 4.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Edwards Lifesciences' (EW) Q2 Earnings?

Edwards Lifesciences (EW) is likely to deliver a solid second quarter on robust segmental performance.

Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

This $6 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies

Edwards Lifesciences Recalls Heart Device on Balloon Rupture

Shares of Edwards Lifesciences (EW) decline post product recall news.

Urmimala Biswas headshot

CMS' Final Verdict on TAVR: A Boon or Bane for MedTech?

While the industry bigwigs are keen to welcome the new CMS ruling, companies like Heart Valve Voice US are not lagging to pen their resistance against a revised policy.

HOLX or EW: Which Is the Better Value Stock Right Now?

HOLX vs. EW: Which Stock Is the Better Value Option?

DexCom and Companion Medical Collaboration to Support CGM

The collaboration enables InPen users to display real-time insulin data in Dexcom's (DXCM) CLARITY Diabetes Management Software.

Why Is Edwards Lifesciences (EW) Down 2.9% Since Last Earnings Report?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HOLX vs. EW: Which Stock Is the Better Value Option?

HOLX vs. EW: Which Stock Is the Better Value Option?

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

This $4 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies

Masimo Gets CE Mark for ANI Module, Enhances Root Platform

Masimo (MASI) obtains CE mark of the ANI module for the Masimo Root Patient Monitoring and Connectivity Hub, which is likely to strengthen its expanding Root platform.

Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised

Edwards Lifesciences (EW) gains on strong segmental contributions in Q1.

Edwards Lifesciences Takes Over CAS Medical Systems for $100M

This CASMED acquisition is expected to strengthen Edwards Lifesciences' (EW) critical care portfolio and expand its footprint in the smart monitoring technology market.